We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 23 results
  1. Population pharmacokinetic modeling and simulation of choline in healthy Korean subjects after oral administration of choline alfoscerate

    Purpose

    This study aimed to investigate clinical pharmacokinetics (PKs) of choline after oral administration of choline alfoscerate capsule and newly...

    Ae-Gyeoing Im, Go-Wun Choi, ... Hea-Young Cho in Journal of Pharmaceutical Investigation
    Article 14 February 2022
  2. Liquid-filled hard capsule formulation of choline alfoscerate: preparation and in vitro/in vivo evaluation

    Purpose

    The objective of this study was to develop a liquid-filled hard capsule (LFHC) formulation of choline alfoscerate (CA) by screening with empty...

    Sang-wook Woo, Sung-Joo Hwang, Cheong-Weon Cho in Journal of Pharmaceutical Investigation
    Article 12 April 2023
  3. Selection of Neuroprotective Therapy in Patients with Chronic Cerebral Ischemia Taking Account of the Synergism of Drug Interactions

    Objective. To optimize selection of neuroprotective treatment protocols in patients with chronic cerebral ischemia taking account of synergism in...

    O. A. Gromova, I. Yu. Torshin, ... K. V. Rudakov in Neuroscience and Behavioral Physiology
    Article 05 May 2021
  4. Effects of Baclofen on Central Paroxysmal Positional Downbeat Nystagmus

    Paroxysmal positional nystagmus frequently occurs in lesions involving the cerebellum, and has been ascribed to disinhibition and enhanced canal...

    So-Yeon Yun, Jong-Hee Lee, ... Ji-Soo Kim in The Cerebellum
    Article Open access 18 March 2024
  5. Stress, Asthenia, and Cognitive Disorders

    Asthenia is a clinical syndrome that can be manifest in almost all somatic, infectious, and neurological diseases. Initially a protective mechanism...

    E. E. Vasenina, O. A. Gankina, O. S. Levin in Neuroscience and Behavioral Physiology
    Article 01 November 2022
  6. Strategies for develo** Alzheimer’s disease treatments: application of population pharmacokinetic and pharmacodynamic models

    Background

    As the number of Alzheimer's disease (AD) patients steadily increases, many pharmaceutical industries and researchers are making efforts...

    Dong Wook Kang, Seok-** Cho, ... Hea-Young Cho in Journal of Pharmaceutical Investigation
    Article 13 June 2022
  7. Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study

    Background

    Focused ultrasound (FUS)-mediated blood–brain barrier (BBB) opening has shown efficacy in removal of amyloid plaque and improvement of...

    So Hee Park, Kyoungwon Baik, ... ** Woo Chang in Translational Neurodegeneration
    Article Open access 05 November 2021
  8. Post-Covid Asthenia Syndrome

    Objectives. To evaluate the efficacy and safety of combination therapy for patients with post-COVID asthenia syndrome (AS) using the multicomponent...

    D. Kh. Khaibullina, Y. N. Maksimov in Neuroscience and Behavioral Physiology
    Article 01 October 2023
  9. Studies of the Efficacy of Cereton in Mild Cognitive Impairment of the Amnestic Type Based on Testing Lipid Markers

    Objectives. To determine the efficacy and safety of treatment with Cereton (alfoscerate) in patients with mild cognitive impairment syndrome (MCI)...

    A. V. Alesenko, S. I. Gavrilova, ... Ya. B. Fedorova in Neuroscience and Behavioral Physiology
    Article 13 December 2018
  10. Direct and Indirect Neurological Signs of COVID-19

    Objective. To systematize the neurological manifestations of COVID-19. Materials and methods. A systematic computerized analysis of all currently...

    O. A. Gromova, I. Yu. Torshin, ... A. G. Chuchalin in Neuroscience and Behavioral Physiology
    Article 01 September 2021
  11. Recent Progress in the Treatment Strategies for Alzheimer’s Disease

    Alzheimer’s disease (AD) is a neurological ailment that affects older people and causes a steady decline in their cognitive function. The cognitive...
    Protocol 2023
  12. Hyperventilation Increases the Randomness of Ocular Palatal Tremor Waveforms

    Hyperventilation changes the extracellular pH modulating many central pathologies, such as tremor. The questions that remain unanswered are the...

    Wanchat Theeranaew, Hyo-Jung Kim, ... Aasef G. Shaikh in The Cerebellum
    Article 31 July 2020
  13. The Cholinergic Profile as a Target for Rational Therapy of Central Nervous System Diseases and Injuries

    Objective. To conduct a comparative analysis of the clinical efficacy of cholinergic drugs and acetylcholinesterase inhibitors and their combinations...

    I. V. Litvinenko, S. A. Zhivolupov, ... Yu. S. Butakova in Neuroscience and Behavioral Physiology
    Article 22 November 2020
  14. Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial

    Background

    High-dose donepezil is currently prescribed for patients with Alzheimer’s disease (AD) who showed poor or waning response to a lower dose...

    Yun Jeong Hong, Hyun Jeong Han, ... Jae-Hong Lee in Alzheimer's Research & Therapy
    Article Open access 01 May 2019
  15. Regression of Poststroke Aphasia and Concomitant Nonspeech Syndromes Due to Courses of Restorative Therapy Including Intensive Speech Therapy

    Objectives. To analyze clinical indicators and fMRI parameters associated with the therapeutic efficacy of courses of complex restorative therapy...

    V. M. Shklovskij, V. V. Alferova, ... A. B. Guekht in Neuroscience and Behavioral Physiology
    Article 27 November 2019
  16. Effects of Prenatal Seizures on Cognitive and Motor Performance in Mice Offspring (with Emphasis on BDNF and GDNF Levels)

    Prenatal seizures in a mother’s organism exert adverse effects on offspring. We investigated the effects of exposure to prenatal seizures in utero on...

    A. Sabaghi, A. Heirani, ... N. Yosofvand in Neurophysiology
    Article 15 October 2018
  17. Wernicke–Korsakov Syndrome

    Objective. To study the characteristics of the diagnosis and treatment of non-alcoholic-related Wernicke–Korsakov syndrome (WKS). Materials and...

    S. V. Kotov, A. I. Lobakov, ... T. V. Volchenkova in Neuroscience and Behavioral Physiology
    Article 17 November 2017
  18. Effects of Modifications of the Functional State of the Central Cholinergic System on Neurological Deficiency Related to Experimental Traumatic Brain Injury

    Using a 100-point Todd scale, we examined the level of neurological deficiency in male albino rats subjected to dosed experimental traumatic brain...

    S. V. Zyablitsev, S. A. Khudoley, ... Yu. I. Strel’chenko in Neurophysiology
    Article 01 April 2015
  19. Molecular Basis of Cholinergic Changes in Autism Spectrum Disorders and Relevance for Treatment Interventions

    The causes of autism are heterogeneous and still largely unknown. Cholinergic abnormalities are reported in molecular pathological studies conducted...
    Elizabeta B. Mukaetova-Ladinska, Elaine K. Perry in The Molecular Basis of Autism
    Chapter 2015
  20. The effects of dietary choline

    Food intake can influence neuronal functions through different modulators expressed in the brain. The present review is a report through relevant...

    Elisabetta Biasi in Neuroscience Bulletin
    Article 29 September 2011
Did you find what you were looking for? Share feedback.